(A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

Subjects:

Vertebral cancellous tissueμCT parameters are not significantly affected by aging from 16 to 21 weeks, housing type, or microgravity. by Rukmani Cahill (20939813)

“…Nonsignificant trends implicate an effect of spaceflight reducing BV/TV, increasing DA, and reducing Tb.N. Data shown are the mean ±  standard deviation with a scatter plot (ns: non-significant). …”

Burials <i>in situ</i> at the cemetery in Wtórek, Greater Poland, Poland. by Agata Hałuszko (13608045)

CFU-Mk is significantly decreased by GATA1s overexpression in <i>GATA1s</i> strains. by Shiori Matsuo (10492159)

Comparing demographic data (mean values). by Tamer Shousha (10960632)

Subjects:

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

Behaviors with a significant main effect or interaction. by Grace Hecker (18813445)

Subjects:

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

S1 Data - by Marc S. Penn (16624541)

Subjects:

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Env variants displaying negative differential selection (diffsel) upon XBP1s induction tend to be more destabilizing and exhibit greater processing defects than those displaying po... by Jimin Yoon (9646685)

24 hours of ARD results in noticeable decrease in ORO staining. by Moriah Eustice (13813098)

HEp-2 titers and outcomes. by Tejaswini Kulkarni (716851)

Subjects:

S1 Dataset - by Tejaswini Kulkarni (716851)

Subjects:

Triple-modality autoantibody reduction regimen. by Tejaswini Kulkarni (716851)

Subjects:

Patient demographic characteristics. by Tejaswini Kulkarni (716851)

Subjects:

Associations with anti-Hep-2 titers at initiation of therapy. by Tejaswini Kulkarni (716851)

Subjects:

HEp-2 indirect Immunofluorescence (IFA) of IPF Plasma. by Tejaswini Kulkarni (716851)

Subjects:

Overall survival and responses to autoantibody reduction therapy. by Tejaswini Kulkarni (716851)

Subjects:

Results of mean differences. by Ekkarat Meephu (15307058)

“…A simulation was conducted to identify 20 scenarios in order to discover the optimal scenario in which where the number of requests (stretchers or wheelchairs) was increased, while the number of staff was decreased to determine mean waiting times and confidence intervals. …”